Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
English version
Kuros Biosciences enters convertible bond financing agreement for up to CHF 5 million
Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
Kuros Biosciences signs agreement to supply SeaSpine with bone graft incorporating Kuros's advanced submicron surface technology
Kuros ends transformational year with first MagnetOs sales, lead clinical program on track, and successful capital raise
Kuros announces final result of capital increase – total gross proceeds of 16.1 million raised